Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration
A Luaces-Rodriguez, C Mondelo-Garcia… - International Journal of …, 2020 - Elsevier
Age-related macular degeneration is the most common cause of vision loss in elderly
people in developed countries. Nowadays, in clinical practice, three anti-VEGF drugs are …
people in developed countries. Nowadays, in clinical practice, three anti-VEGF drugs are …
Pharmacological advances in the treatment of age-related macular degeneration
M Gil-Martínez, P Santos-Ramos… - Current medicinal …, 2020 - ingentaconnect.com
Age-related macular degeneration is an acquired degenerative disease that is responsible
for severe loss of vision in elderly people. There are two types: dry age-related macular …
for severe loss of vision in elderly people. There are two types: dry age-related macular …
Retinal and Choroidal Neovascularization Antivascular Endothelial Growth Factor Treatments: The Role of Gene Therapy
S Toutounchian, N Ahmadbeigi… - Journal of Ocular …, 2022 - liebertpub.com
Neovascularization in ocular vessels causes a major disease burden. The most common
causes of choroidal neovascularization (CNV) are age-related macular degeneration and …
causes of choroidal neovascularization (CNV) are age-related macular degeneration and …
Monolithic Devices for Sustained Delivery of Protein Therapeutics for Ocular Disease
TM Rodriguez, DA Bernards, TA Desai - 2021 - books.rsc.org
Vision impairments affect over a quarter of the world's population. 1 In 2015, it was estimated
that 217 million people experienced moderate or severe vision impairment, where 84 …
that 217 million people experienced moderate or severe vision impairment, where 84 …